Search

Sanofi

Закрыт

47 0.23

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

45.44

Макс.

47.15

Ключевые показатели

By Trading Economics

Доход

-1.3B

343M

Продажи

1.1B

12B

P/E

Средняя по отрасли

22.662

51.78

Прибыль на акцию

2.04

Рентабельность продаж

2.789

Сотрудники

74,846

EBITDA

1.3B

4B

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+26.84% upside

Рыночная статистика

By TradingEconomics

Рыночная капитализация

4.3B

109B

Предыдущая цена открытия

46.77

Предыдущая цена закрытия

47

Sanofi График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

6 нояб. 2026 г., 23:56 UTC

Kyndryl Holdings, Inc. is trading modestly higher in after-market hours, remaining significantly above its 20-day moving average and near the upper end of its one-month trading range.

6 нояб. 2026 г., 23:56 UTC

Ciena Corporation shares are trading modestly higher in after-market hours.

6 нояб. 2026 г., 23:52 UTC

Hecla Mining Co is trading lower in after-hours activity, shifting from a slight gain to a modest loss since Friday's close.

6 нояб. 2026 г., 23:51 UTC

Uniti Group Inc is trading higher in after-market hours following Friday's close, marking a significant recovery.

6 нояб. 2026 г., 23:51 UTC

West Pharmaceutical Services, Inc. has traded lower in after-market hours, reversing an initial uptick and settling around the middle of its one-month trading range.

6 нояб. 2026 г., 23:51 UTC

Extra Space Storage Inc. is trading higher in after-market hours, advancing significantly since Friday's close and reaching a high return by session's end.

6 нояб. 2026 г., 23:51 UTC

News

UBS maintains a Sell rating on Dropbox Inc and raises its price target to $26, contributing to the stock's after-market decline.

6 нояб. 2026 г., 23:51 UTC

Progyny, Inc. shares are trading lower in after-market hours, continuing a decline that has deepened despite recent higher closes over the last three sessions.

6 нояб. 2026 г., 23:51 UTC

Halozyme Therapeutics, Inc. is trading modestly higher in after-market hours, maintaining a firm position above earlier lows.

6 нояб. 2026 г., 23:51 UTC

Camden National Corp shares are trading lower in after-market hours following Friday's close.

6 нояб. 2026 г., 23:51 UTC

Cogent Communications Holdings, Inc. is advancing in after-market trading following Friday's close.

6 нояб. 2026 г., 23:51 UTC

News

Viridian Therapeutics will host a conference call on November 9, 2026, to present data from its VRDN-008 phase 1 clinical trial and discuss development plans.

6 нояб. 2026 г., 23:51 UTC

Correlated Moves

Rockwell Automation Inc is trading modestly higher in after-market hours, recovering from an earlier low and benefiting from gains in argenx SE.

6 нояб. 2026 г., 23:51 UTC

Correlated Moves

MARA Holdings, Inc. is trading lower in after-market hours, ending significantly below its 20-day moving average amid a notable decline throughout the session.

6 нояб. 2026 г., 23:51 UTC

Target Corp shares are trading slightly lower in after-market hours, reflecting a modest decline since Friday's close while remaining above its 20-day moving average.

6 нояб. 2026 г., 23:46 UTC

Waters Corp shares traded modestly higher in after-market hours, supported by strong job growth and a decrease in the unemployment rate to 4.1%.

6 нояб. 2026 г., 23:46 UTC

Rhythm Pharmaceuticals, Inc. is experiencing a slight decline in after-market trading, moving lower from a peak shortly after the market closed.

6 нояб. 2026 г., 23:46 UTC

Correlated Moves

Accenture PLC shares declined modestly in after-market trading, following a broader market trend, while Fiserv Inc also traded slightly lower during the same period.

6 нояб. 2026 г., 23:46 UTC

Correlated Moves

Permian Resources Corporation's shares advanced modestly in after-market trading, maintaining a position above Friday's close amid slight fluctuations during the session.

6 нояб. 2026 г., 23:46 UTC

Futu Holdings Limited is seeing an increase in after-market trading, reaching its highest level since Friday's close.

6 нояб. 2026 г., 23:46 UTC

Twist Bioscience Corporation is trading modestly higher in after-market hours following Friday's close.

6 нояб. 2026 г., 23:42 UTC

Consolidated Edison, Inc. shares advanced modestly higher in after-market trading, currently positioned above its 20-day moving average and near the upper end of its one-month range.

6 нояб. 2026 г., 23:42 UTC

Duke Energy Corp is trading higher in after-market hours, advancing sharply since Friday's close and positioned above its 20-day moving average.

6 нояб. 2026 г., 23:41 UTC

KeyCorp's shares are advancing in after-market trading, reflecting strong momentum since Friday's close and trading above its 20-day moving average.

6 нояб. 2026 г., 23:41 UTC

Yum China Holdings Inc is experiencing a modest decline in after-market trading, retracing from an initial peak to its lowest point of the day.

6 нояб. 2026 г., 23:41 UTC

Sun Communities Inc is experiencing a significant decline in after-market trading, moving lower since Friday's close and dropping from a brief session high.

6 нояб. 2026 г., 23:41 UTC

Nucor Corporation is seeing a notable increase in after-market trading, reaching its highest cumulative return of the day.

6 нояб. 2026 г., 23:41 UTC

Bank OZK shares declined in after-market trading, pulling back from an earlier flat position to a notable low since Friday's close.

6 нояб. 2026 г., 23:41 UTC

Pacific Biosciences of California, Inc. is trading modestly lower in after-market hours, marking its fourth consecutive session of declines.

6 нояб. 2026 г., 23:41 UTC

Enovix Corporation shares fell during after-market hours on Friday, retreating sharply to close at the session's low end, remaining below the 20-day moving average.

Сравнение c конкурентами

Изменение цены

Sanofi Прогноз

Целевая цена

By TipRanks

26.84% рост

Прогноз на 12 месяцев

Средняя 59.5 USD  26.84%

Максимум 62 USD

Минимум 57 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Sanofi на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

2 ratings

1

Покупка

1

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
help-icon Live chat